FLOMAX

Drug Boehringer Ingelheim Pharmaceuticals, Inc.
Total Payments
$14,681
Transactions
13
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $4,231 1 1
2018 $30.66 2 2
2017 $10,419 10 5

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,632 10 99.7%
Food and Beverage $48.33 3 0.3%

Top Doctors Receiving Payments for FLOMAX

Doctor Specialty Location Total Records
, MD Urology Dallas, TX $5,740 3
, MD Urology New York, NY $5,350 3
, M.D Specialist Aventura, FL $2,331 3
, MD Urology Miami, FL $1,212 1
, D.O Internal Medicine Sumter, SC $17.67 1
, MD Internal Medicine Las Vegas, NV $15.33 1
, MD Internal Medicine Las Vegas, NV $15.33 1

About FLOMAX

FLOMAX is a drug associated with $14,681 in payments to 7 healthcare providers, recorded across 13 transactions in the CMS Open Payments database. The primary manufacturer is Boehringer Ingelheim Pharmaceuticals, Inc..

Payment data is available from 2017 to 2019. In 2019, $4,231 was paid across 1 transactions to 1 doctors.

The most common payment nature for FLOMAX is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($14,632, 99.7% of total).